89bio Inc Stock Investor Sentiment
| ETNB Stock | USD 8.99 0.15 1.64% |
About 56% of 89bio's investor base is looking to short. The analysis of the overall investor sentiment regarding 89bio Inc suggests that many traders are alarmed. The current market sentiment, together with 89bio's historical and current headlines, can help investors time the market. In addition, many technical investors use 89bio Inc stock news signals to limit their universe of possible portfolio assets.
89bio |
89bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards 89bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about 89bio that are available to investors today. That information is available publicly through 89bio media outlets and privately through word of mouth or via 89bio internal channels. However, regardless of the origin, that massive amount of 89bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of 89bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of 89bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to 89bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive 89bio alpha.
89bio Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 16527 shares by Rohan Palekar of 89bio at 18.95 subject to Rule 16b-3 | 09/06/2024 |
2 | Disposition of 5352 shares by Le-nguyen Quoc of 89bio at 8.46 subject to Rule 16b-3 | 09/09/2024 |
3 | Disposition of 9671 shares by Mansbach Harry H of 89bio at 11.53 subject to Rule 16b-3 | 09/27/2024 |
4 | Acquisition by Le-nguyen Quoc of 8334 shares of 89bio subject to Rule 16b-3 | 10/14/2024 |
5 | 89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis at AASLD The Liver Meeting 2024 | 10/15/2024 |
6 | Short Interest in 89bio, Inc. Declines By 7.1 | 10/18/2024 |
7 | Disposition of 27955 shares by Le-nguyen Quoc of 89bio at 8.12 subject to Rule 16b-3 | 10/30/2024 |
8 | Acquisition by Atkinson Edward Morrow Iii of 45150 shares of 89bio at 9.98 subject to Rule 16b-3 | 11/07/2024 |
9 | 89bio Launches 100M Public Offering to Advance Pegozafermin Development ETNB ETNB Stock News - StockTitan | 11/12/2024 |
10 | 89bio drops 2, prices 125M stock offering | 11/13/2024 |
11 | Janus Henderson Group PLCs Strategic Acquisition in 89bio Inc | 11/14/2024 |
12 | RA CAPITAL MANAGEMENT, L.P. Increases Stake in 89bio Inc - GuruFocus.com | 11/19/2024 |
13 | Acquisition by Rohan Palekar of 10000 shares of 89bio at 8.35 subject to Rule 16b-3 | 11/22/2024 |
14 | Acquisition by Le-nguyen Quoc of 195000 shares of 89bio at 9.98 subject to Rule 16b-3 | 11/25/2024 |
15 | 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635 | 11/29/2024 |
Complementary Tools for 89bio Stock analysis
When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |